Philanthropy can help bridge Singapore’s medical research funding gap
Add BT as a preferred source
SINGAPORE is strategically placed to establish itself as Asia’s centre for medical research and healthcare. With an enviable combination of scientific prowess, a conducive environment that draws top talent from across the globe and committed support from the government, the Little Red Dot has the potential to become a powerhouse in this sector.
This is showcased by the recent Research, Innovation and Enterprise 2025 Plan, which saw the government earmark a record S$25 billion for this strategic initiative, a significant increase from 2020’s S$19 billion. Of this new budget, S$6.5 billion is dedicated to the plan’s expanded mission, which emphasises human health and potential.
Nevertheless, the journey is still evolving, and challenges like the “valley of death” in medical research need to be addressed head-on for the city-state to fully realise its research potential.
TRENDING NOW
Singtel Q1 gain drops 71% to S$818 million in absence of Airtel stake sale; weaker Singapore business
Sembcorp raises interim dividend despite 72% H1 profit slide to S$150 million on Alinta deal costs
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
CDL H1 profit jumps three times to S$301 million on strong condo sales, doubles interim dividend
